ebv1

Treatment resistance in diffuse large

Therapy resistance in diffuse massive B-cell lymphoma

Diffuse massive B-cell lymphoma (DLBCL) is a extremely heterogeneous illness and represents the most typical subtype of lymphoma. Though 60-70% of all sufferers will be cured by the present normal of care within the frontline setting, nearly all of the remaining sufferers will expertise remedy resistance and have a poor medical consequence. Quite a few efforts have been made to enhance the efficacy of the usual routine by, for instance, dose intensification or including novel brokers. Nevertheless, these outcomes typically did not exhibit important medical advantages.

Therefore, understanding remedy resistance is a urgent have to optimize the end result of these sufferers. On this Evaluate, we first describe the conceptual sources of remedy resistance in DLBCL after which present detailed and up-to-date molecular perception into the mechanisms of resistance to the present remedy choices in DLBCL. We lastly spotlight the potential methods for rationally managing remedy resistance from each the preventive and interventional views.

ebv1
ebv1

CMV Control lentiviral particles (RFP-Bsd)

CMV-Null-RB 1 x107 IFU/ml x 200ul
EUR 349
Description: Negative control lentivirus contains a null spacer insert under CMV promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the RFP-Blasticidin fusion marker under RSV promoter.

CMV Control lentiviral particles (RFP-Puro)

CMV-Null-RP 1 x107 IFU/ml x 200ul
EUR 349
Description: Negative control lentivirus contains a null spacer insert under CMV promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the RFP-Puromycin fusion marker under RSV promoter.

CMV control lentivirus (Hygro)

CMV-Null-Hygro 1 x107 IFU/ml x 200ul
EUR 349
Description: Negative control lentivirus contains a null spacer insert under CMV promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It has the hygromycin selection under RSV promoter.

CMV control lentivirus (Zeo)

CMV-Null-Zeo 1 x107 IFU/ml x 200ul
EUR 349
Description: Negative control lentivirus contains a null spacer insert under CMV promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It has the Zeocin selection under RSV promoter.

CMV Control lentiviral particles (Bsd) in PBS

CMV-Null-Bsd-PBS 1 x108 IFU/ml x 200ul
EUR 710
Description: Negative control lentivirus contains a null spacer insert under CMV promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the blasticidin marker under RSV promoter. The virus was concentrated and provided in PBS solution.

CMV Control lentiviral particles (Neo) in PBS

CMV-Null-Neo-PBS 1 x108 IFU/ml x 200ul
EUR 710
Description: Negative control lentivirus contains a null spacer insert under CMV promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the Neomycin marker under RSV promoter. The virus was concentrated and provided in PBS solution.

CMV Control lentiviral particles (Puro) in PBS

CMV-Null-Puro-PBS 1 x108 IFU/ml x 200ul
EUR 710
Description: Negative control lentivirus contains a null spacer insert under CMV promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the Puromycin marker under RSV promoter. The virus was concentrated and provided in PBS solution.

CMV Control lentiviral particles (GFP-Bsd) in PBS

CMV-Null-GB-PBS 1 x108 IFU/ml x 200ul
EUR 710
Description: Negative control lentivirus contains a null spacer insert under CMV promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the GFP-Blasticidin fusion marker under RSV promoter. The virus was concentrated and provided in PBS solution.

CMV Control lentiviral particles (GFP-Puro) in PBS

CMV-Null-GP-PBS 1 x108 IFU/ml x 200ul
EUR 710
Description: Negative control lentivirus contains a null spacer insert under CMV promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the GFP-Puromycin fusion marker under RSV promoter. The virus was concentrated and provided in PBS solution.

CMV Control lentiviral particles (RFP-Bsd) in PBS

CMV-Null-RB-PBS 1 x108 IFU/ml x 200ul
EUR 710
Description: Negative control lentivirus contains a null spacer insert under CMV promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the RFP-Blasticidin fusion marker under RSV promoter. The virus was concentrated and provided in PBS solution.

CMV Control lentiviral particles (RFP-Puro) in PBS

CMV-Null-RP-PBS 1 x108 IFU/ml x 200ul
EUR 710
Description: Negative control lentivirus contains a null spacer insert under CMV promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the RFP-Puromycin fusion marker under RSV promoter. The virus was concentrated and provided in PBS solution.

DRD5P1 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723353 1.0 ug DNA Ask for price

DRD5P2 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723359 1.0 ug DNA Ask for price

DSTNP1 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723383 1.0 ug DNA Ask for price

DSTNP3 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723389 1.0 ug DNA Ask for price

DTX2P1 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723395 1.0 ug DNA Ask for price

DURS1 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723401 1.0 ug DNA Ask for price

DUSPP Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723407 1.0 ug DNA Ask for price

DUTP1 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723413 1.0 ug DNA Ask for price

DUTP2 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723419 1.0 ug DNA Ask for price

DUTP4 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723425 1.0 ug DNA Ask for price

DUTP5 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723431 1.0 ug DNA Ask for price

DUTP6 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723437 1.0 ug DNA Ask for price

DUTP7 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723443 1.0 ug DNA Ask for price

DUTP8 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723449 1.0 ug DNA Ask for price

DUX4L8 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723455 1.0 ug DNA Ask for price

DUX4L10 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723461 1.0 ug DNA Ask for price

DUX4L11 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723467 1.0 ug DNA Ask for price

DUX4L14 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723473 1.0 ug DNA Ask for price

DUX4L16 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723479 1.0 ug DNA Ask for price

DUX4L17 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723485 1.0 ug DNA Ask for price

DUX4L18 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723491 1.0 ug DNA Ask for price

DUX4L19 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723497 1.0 ug DNA Ask for price

DUXB Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723503 1.0 ug DNA Ask for price

DVL1L1 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723509 1.0 ug DNA Ask for price

DWS Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723515 1.0 ug DNA Ask for price

DYNLL1P2 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723521 1.0 ug DNA Ask for price

DYRK1AIP1 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723527 1.0 ug DNA Ask for price

DYRK1AIP2 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723533 1.0 ug DNA Ask for price

DYT2 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723539 1.0 ug DNA Ask for price

DYT4 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723545 1.0 ug DNA Ask for price

DYT7 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723551 1.0 ug DNA Ask for price

DYT10 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723557 1.0 ug DNA Ask for price

DYT13 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723563 1.0 ug DNA Ask for price

DYT15 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723569 1.0 ug DNA Ask for price

DYT17 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723575 1.0 ug DNA Ask for price

DYT21 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723581 1.0 ug DNA Ask for price

DYT22 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723587 1.0 ug DNA Ask for price

DYX1 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723593 1.0 ug DNA Ask for price

DYX2 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723605 1.0 ug DNA Ask for price

DYX3 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723611 1.0 ug DNA Ask for price

DYX4 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723617 1.0 ug DNA Ask for price

DYX5 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723623 1.0 ug DNA Ask for price

DYX6 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723629 1.0 ug DNA Ask for price

DYX7 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723635 1.0 ug DNA Ask for price

DYX8 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723641 1.0 ug DNA Ask for price

DYX9 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723647 1.0 ug DNA Ask for price

E2F3P2 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723659 1.0 ug DNA Ask for price

E2F4P1 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723665 1.0 ug DNA Ask for price

E11S Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723671 1.0 ug DNA Ask for price

EBM Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723683 1.0 ug DNA Ask for price

EBR3 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723689 1.0 ug DNA Ask for price

EBR4 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723695 1.0 ug DNA Ask for price

EBVM1 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723701 1.0 ug DNA Ask for price

EBVS1 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723707 1.0 ug DNA Ask for price

ECA1 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723713 1.0 ug DNA Ask for price

ECEL1P1 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723719 1.0 ug DNA Ask for price

ECEL1P3 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723725 1.0 ug DNA Ask for price

EDDM3DP Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723731 1.0 ug DNA Ask for price

EEC1 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723737 1.0 ug DNA Ask for price

EEC2 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723743 1.0 ug DNA Ask for price

EEF1A1P3 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723749 1.0 ug DNA Ask for price

EEF1A1P4 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723755 1.0 ug DNA Ask for price

EEF1A1P15 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723761 1.0 ug DNA Ask for price

EEF1A1P16 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723767 1.0 ug DNA Ask for price

EEF1A1P17 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723773 1.0 ug DNA Ask for price

EEF1A1P18 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723779 1.0 ug DNA Ask for price

EEF1A1P22 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723785 1.0 ug DNA Ask for price

EEF1A1P23 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723791 1.0 ug DNA Ask for price

EEF1A1P25 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723797 1.0 ug DNA Ask for price

EEF1A1P26 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723803 1.0 ug DNA Ask for price

EEF1A1P28 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723809 1.0 ug DNA Ask for price

EEF1A1P29 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723815 1.0 ug DNA Ask for price

EEF1A1P30 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723821 1.0 ug DNA Ask for price

EEF1A1P31 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723827 1.0 ug DNA Ask for price

EEF1A1P33 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723833 1.0 ug DNA Ask for price

EEF1A1P34 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723839 1.0 ug DNA Ask for price

EEF1A1P35 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723845 1.0 ug DNA Ask for price

EEF1A1P38 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723851 1.0 ug DNA Ask for price

EEF1A1P40 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723857 1.0 ug DNA Ask for price

EEF1A1P41 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723863 1.0 ug DNA Ask for price

EEF1A3 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723869 1.0 ug DNA Ask for price

EEF1B2P5 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723875 1.0 ug DNA Ask for price

EEF1DP1 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723881 1.0 ug DNA Ask for price

EEF1DP4 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723887 1.0 ug DNA Ask for price

Resistant hyponatraemia in a affected person with follicular lymphoma and coronary heart failure with decreased ejection fraction: a case report

Background: Hyponatraemia is a frequent drawback in sufferers with coronary heart failure. It may be tough to deal with, particularly within the presence of the affected person’s wants for diuresis and manipulation of the renin-angiotensin-aldosterone system (RAAS).

Case abstract: This issues a 74-year-old lady with follicular lymphoma and extreme world left ventricular systolic dysfunction secondary to remedy with R-CHOP chemotherapy. She offered a tough problem within the administration of her decompensated coronary heart failure alongside hyponatraemia as little as 113 mmol/L. This was resistant to plain remedy. The resistance to typical measures necessitated remedy with Tolvaptan, a selective arginine vasopressin V2 inhibitor used to deal with hyponatraemia in syndrome of inappropriate anti-diuretic hormone. This, together with a strict fluid restriction of 500 mL/day, resolved the affected person’s hyponatraemia and enabled her discharge house on tolerated coronary heart failure remedy. She has now remained steady for nearly 12 months.

Dialogue: The potential causes of hyponatraemia are mentioned together with the function of Tolvaptan in its administration.

Regional Mind Glucose Metabolism and Its Prognostic Worth in Pretreatment Extranodal Pure Killer/T-Cell Lymphoma Sufferers

Goal: To discover regional mind glucose metabolic abnormalities of pretreatment stage I/II extranodal pure killer/T-cell lymphoma (ENKTL) sufferers utilizing positron emission tomography with 2-deoxy-2-[fluorine-18]fluoro-D-glucose built-in with computed tomography (18F-FDG PET/CT) and assess its prognostic worth.

Strategies: Sixty pretreatment stage I/II ENKTL sufferers have been enrolled on this retrospective examine and divided into survival (n = 45) and loss of life (n = 15) teams in response to their standing on the finish of follow-up. A management group consisted of 60 wholesome topics. Regional cerebral glucose metabolism was evaluated on a voxel-by-voxel foundation utilizing statistical parametric mapping (SPM8) underneath a sure significance stage (P < 0. 001) and voxel threshold (Ok = 100 voxels).

Outcomes: Decreased metabolism was famous in sufferers, involving the bilateral prefrontal and orbitofrontal cortex, partial parietal and occipital cortex, cingulate gyrus and cerebellum; the sensorimotor cortex was largely spared. Elevated metabolism was noticed within the bilateral putamen, amygdala, and parahippocampal gyrus. In contrast with the survival group, the loss of life group had greater metabolism within the bilateral amygdala, putamen, left thalamus, uncus, and parahippocampal gyrus. Solely B signs have been related to the elevated metabolism of basal ganglia and thalamus (BGT). Sufferers with excessive metabolic tumor quantity, complete lesion glycolysis (TLG) and BGT metabolism had a poor prognosis. TLG and most standardized uptake worth (SUVmax) LBGT/SUVmaxRight cerebellum have been related to Jap Cooperative Oncology Group (ECOG) and prognostic index of pure killer lymphoma and Epstein-Barr virus-DNA (PINKE) scores. In multivariate evaluation, solely ECOG was an unbiased prognostic issue of each progression-free survival (PFS) and total survival (OS). PINKE was an unbiased prognostic issue of OS.

Conclusion: Pretreatment stage I/II ENKTL sufferers exhibited irregular regional cerebral glucose metabolism. Greater pretreatment glucose metabolism in BGT might predict a comparatively poor prognosis however didn’t surpass the predictive values of ECOG and PINKE in stage I/II ENKTL sufferers.

Prognosis and Individualized Therapy of Secondary Central Nervous System Lymphoma: A Case Report

Non-Hodgkin lymphoma can disseminate to the central nervous system at initiation of remedy for systemic lymphoma or unfold in the course of the relapse of systematic lymphoma with CNS involvement, which is outlined as secondary central nervous system lymphoma (SCNSL). The incidence of SCNSL relies on the pathological sort of lymphoma and is very excessive in aggressive lymphoma. SCNSL has a poor prognosis due to the shortage of efficient remedy regimens.

This text presents a uncommon case of SCNSL; an individualized remedy routine was designed in response to the genetic analyses of the affected person tumor and included a Bruton’s tyrosine kinase (BTK) inhibitor. After six cycles of remedy and one other two cycles of rituximab, most lesions misplaced their metabolic exercise. Nevertheless, within the last stage of remedy, our affected person sadly suffered from respiratory failure, which revealed that we must always pay consideration to Pneumocystis jirovecii pneumonia throughout ibrutinib remedy.

The medical potential of circulating immune cell counts in major gastric lymphoma

Background: Excessive neutrophil-lymphocyte ratio (NLR) is linked to poor total survival (OS) in gastrointestinal tract cancers. This examine explores the medical worth of NLR, along with absolute lymphocyte rely (ALC) and different hematologic parameters in affiliation with distant metastases and OS in major gastric lymphoma (PGL) sufferers.

Strategies: Scientific information of 139 PGL sufferers who acquired remedy at King Hussein Most cancers Middle (KHCC), Amman-Jordan have been retrospectively evaluated. Utilizing information from full blood rely (CBC) exams, the next hematologic parameters: absolute neutrophil rely (ANC), ALC, absolute eosinophil rely (AEC), absolute monocyte rely (AMC), NLR, platelet-lymphocyte ratio (PLR), and monocyte-lymphocyte ratio (MLR) have been assessed in affiliation with the next medical outcomes: presence or absence of baseline distant metastases and OS. We carried out univariate and multivariate analyses assessing the varied hematologic parameters in affiliation with distant metastases.

Outcomes: Univariate and multivariate analyses indicated that sufferers with an elevated NLR (>3.14) displayed extra baseline distant metastases in comparison with sufferers with a low NLR (≤3.14), (P worth: 0.02 and 0.018, respectively). Excessive baseline ALC (>1,819/µL) was related to decrease baseline distant metastases (P worth: 0.04). Within the OS evaluation, excessive baseline ANC (>5,100/µL), NLR (>2.75), and PLR (>0.16) have been related to poor OS, (P worth: 0.027, 0.016, and 0.011 respectively).

Conclusions: Excessive NLR and ALC have been related to baseline distant metastases. Excessive baseline ANC, NLR, and PLR have been related to poor OS. Hematologic parameters could be probably useful in assessing and correlating NLR with the response success to remedy in PGL.

EF1a Control lentiviral particles (RFP-Bsd)
EF1a-Null-RB 1 x107 IFU/ml x 200ul
EUR 349
Description: Negative control lentivirus contains a null spacer insert under EF1a promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the RFP-Blasticidin fusion marker under RSV promoter.
EF1a Control lentiviral particles (RFP-Puro)
EF1a-Null-RP 1 x107 IFU/ml x 200ul
EUR 349
Description: Negative control lentivirus contains a null spacer insert under EF1a promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the RFP-Puromycin fusion marker under RSV promoter.
EF1a control lentivirus (Hygro)
EF1a-Null-Hygro 1 x107 IFU/ml x 200ul
EUR 349
Description: Negative control lentivirus contains a null spacer insert under EF1a promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It has the hygromycin selection under RSV promoter.
EF1a control lentivirus (Zeo)
EF1a-Null-Zeo 1 x107 IFU/ml x 200ul
EUR 349
Description: Negative control lentivirus contains a null spacer insert under EF1a promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It has the Zeocin selection under RSV promoter.
EF1a Control lentiviral particles (Bsd) in PBS
EF1a-Null-Bsd-PBS 1 x108 IFU/ml x 200ul
EUR 710
Description: Negative control lentivirus contains a null spacer insert under EF1a promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the blasticidin marker under RSV promoter. The virus was concentrated and provided in PBS solution.
EF1a Control lentiviral particles (Neo) in PBS
EF1a-Null-Neo-PBS 1 x108 IFU/ml x 200ul
EUR 710
Description: Negative control lentivirus contains a null spacer insert under EF1a promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the Neomycin marker under RSV promoter. The virus was concentrated and provided in PBS solution.
EF1a Control lentiviral particles (Puro) in PBS
EF1a-Null-Puro-PBS 1 x108 IFU/ml x 200ul
EUR 710
Description: Negative control lentivirus contains a null spacer insert under EF1a promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the Puromycin marker under RSV promoter. The virus was concentrated and provided in PBS solution.
EF1a Control lentiviral particles (GFP-Bsd) in PBS
EF1a-Null-GB-PBS 1 x108 IFU/ml x 200ul
EUR 710
Description: Negative control lentivirus contains a null spacer insert under EF1a promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the GFP-Blasticidin fusion marker under RSV promoter. The virus was concentrated and provided in PBS solution.
EF1a Control lentiviral particles (GFP-Puro) in PBS
EF1a-Null-GP-PBS 1 x108 IFU/ml x 200ul
EUR 710
Description: Negative control lentivirus contains a null spacer insert under EF1a promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the GFP-Puromycin fusion marker under RSV promoter. The virus was concentrated and provided in PBS solution.
EF1a Control lentiviral particles (RFP-Bsd) in PBS
EF1a-Null-RB-PBS 1 x108 IFU/ml x 200ul
EUR 710
Description: Negative control lentivirus contains a null spacer insert under EF1a promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the RFP-Blasticidin fusion marker under RSV promoter. The virus was concentrated and provided in PBS solution.
EF1a Control lentiviral particles (RFP-Puro) in PBS
EF1a-Null-RP-PBS 1 x108 IFU/ml x 200ul
EUR 710
Description: Negative control lentivirus contains a null spacer insert under EF1a promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the RFP-Puromycin fusion marker under RSV promoter. The virus was concentrated and provided in PBS solution.
DPY19L1P2 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)
LV723334 1.0 ug DNA Ask for price
DRD5P1 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)
LV723358 1.0 ug DNA Ask for price
DRD5P2 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)
LV723364 1.0 ug DNA Ask for price
DSTNP1 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)
LV723388 1.0 ug DNA Ask for price
DSTNP3 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)
LV723394 1.0 ug DNA Ask for price
DTX2P1 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)
LV723400 1.0 ug DNA Ask for price
DURS1 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)
LV723406 1.0 ug DNA Ask for price
DUSPP Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)
LV723412 1.0 ug DNA Ask for price
DUTP1 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)
LV723418 1.0 ug DNA Ask for price
DUTP2 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)
LV723424 1.0 ug DNA Ask for price
DUTP4 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)
LV723430 1.0 ug DNA Ask for price
DUTP5 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)
LV723436 1.0 ug DNA Ask for price
DUTP6 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)
LV723442 1.0 ug DNA Ask for price
DUTP7 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)
LV723448 1.0 ug DNA Ask for price
DUTP8 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)
LV723454 1.0 ug DNA Ask for price
DUX4L8 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)
LV723460 1.0 ug DNA Ask for price
DUX4L10 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)
LV723466 1.0 ug DNA Ask for price
DUX4L11 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)
LV723472 1.0 ug DNA Ask for price
DUX4L14 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)
LV723478 1.0 ug DNA Ask for price
DUX4L16 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)
LV723484 1.0 ug DNA Ask for price
DUX4L17 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)
LV723490 1.0 ug DNA Ask for price
DUX4L18 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)
LV723496 1.0 ug DNA Ask for price
DUX4L19 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)
LV723502 1.0 ug DNA Ask for price
DUXB Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)
LV723508 1.0 ug DNA Ask for price
DVL1L1 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)
LV723514 1.0 ug DNA Ask for price
DWS Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)
LV723520 1.0 ug DNA Ask for price
DYNLL1P2 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)
LV723526 1.0 ug DNA Ask for price
DYRK1AIP1 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)
LV723532 1.0 ug DNA Ask for price
DYRK1AIP2 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)
LV723538 1.0 ug DNA Ask for price
DYT2 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)
LV723544 1.0 ug DNA Ask for price
DYT4 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)
LV723550 1.0 ug DNA Ask for price
DYT7 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)
LV723556 1.0 ug DNA Ask for price
DYT10 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)
LV723562 1.0 ug DNA Ask for price
DYT13 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)
LV723568 1.0 ug DNA Ask for price
DYT15 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)
LV723574 1.0 ug DNA Ask for price
DYT17 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)
LV723580 1.0 ug DNA Ask for price
DYT21 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)
LV723586 1.0 ug DNA Ask for price
DYT22 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)
LV723592 1.0 ug DNA Ask for price
DYX1 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)
LV723598 1.0 ug DNA Ask for price
DYX2 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)
LV723610 1.0 ug DNA Ask for price
DYX3 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)
LV723616 1.0 ug DNA Ask for price
DYX4 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)
LV723622 1.0 ug DNA Ask for price
DYX5 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)
LV723628 1.0 ug DNA Ask for price
DYX6 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)
LV723634 1.0 ug DNA Ask for price
DYX7 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)
LV723640 1.0 ug DNA Ask for price
DYX8 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)
LV723646 1.0 ug DNA Ask for price
DYX9 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)
LV723652 1.0 ug DNA Ask for price
E2F3P2 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)
LV723664 1.0 ug DNA Ask for price
E2F4P1 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)
LV723670 1.0 ug DNA Ask for price
E11S Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)
LV723676 1.0 ug DNA Ask for price
EBM Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)
LV723688 1.0 ug DNA Ask for price
EBR3 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)
LV723694 1.0 ug DNA Ask for price
EBR4 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)
LV723700 1.0 ug DNA Ask for price
EBVM1 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)
LV723706 1.0 ug DNA Ask for price
EBVS1 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)
LV723712 1.0 ug DNA Ask for price
ECA1 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)
LV723718 1.0 ug DNA Ask for price
ECEL1P1 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)
LV723724 1.0 ug DNA Ask for price
ECEL1P3 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)
LV723730 1.0 ug DNA Ask for price
EDDM3DP Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)
LV723736 1.0 ug DNA Ask for price
EEC1 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)
LV723742 1.0 ug DNA Ask for price
EEC2 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)
LV723748 1.0 ug DNA Ask for price
EEF1A1P3 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)
LV723754 1.0 ug DNA Ask for price
EEF1A1P4 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)
LV723760 1.0 ug DNA Ask for price
EEF1A1P15 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)
LV723766 1.0 ug DNA Ask for price
EEF1A1P16 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)
LV723772 1.0 ug DNA Ask for price
EEF1A1P17 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)
LV723778 1.0 ug DNA Ask for price
EEF1A1P18 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)
LV723784 1.0 ug DNA Ask for price
EEF1A1P22 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)
LV723790 1.0 ug DNA Ask for price
EEF1A1P23 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)
LV723796 1.0 ug DNA Ask for price
EEF1A1P25 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)
LV723802 1.0 ug DNA Ask for price
EEF1A1P26 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)
LV723808 1.0 ug DNA Ask for price
EEF1A1P28 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)
LV723814 1.0 ug DNA Ask for price
EEF1A1P29 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)
LV723820 1.0 ug DNA Ask for price
EEF1A1P30 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)
LV723826 1.0 ug DNA Ask for price
EEF1A1P31 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)
LV723832 1.0 ug DNA Ask for price
EEF1A1P33 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)
LV723838 1.0 ug DNA Ask for price
EEF1A1P34 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)
LV723844 1.0 ug DNA Ask for price
EEF1A1P35 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)
LV723850 1.0 ug DNA Ask for price
EEF1A1P38 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)
LV723856 1.0 ug DNA Ask for price

Leave a Reply

Your email address will not be published. Required fields are marked *